Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06588452 · ClinicalTrials.gov registry record
Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models
A clinical trial of Comparing Manual and AI Patient Screening in Heart Failure, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- 4,500
- Enrollment target
- 1
- Study location
NCT06588452: Recruiting study of Comparing Manual and AI Patient Screening in Heart Failure, sponsored by Brigham and Women's Hospital.
NCT06588452 is a study of Comparing Manual and AI Patient Screening in Heart Failure that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 4,500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06588452, a study of Comparing Manual and AI Patient Screening in Heart Failure, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- 4,500 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective randomized controlled trial comparing manual review and AI screening for patient eligibility determination and enrollments. A structured query will identify potentially eligible patients from the Mass General Brigham Electronic Data Warehouse (EDW), who will then be randomized into either the manual review arm or the AI-assisted review arm.
Primary Outcome
Assess the likelihood of eligibility determination, comparing the AI-assisted screening group to the manual screening group accounting for the competing risk of ineligibility determination.
Conditions Studied
Interventions
- OTHER RECTIFIER - a generative artificial intelligence screening tool
- OTHER Manual clinical trial screening by study staff
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,500 participants |
| Start Date | 2024-03-04 |
| Est. Completion | 2024-09-13 |
What NCT06588452 shows while recruiting
NCT06588452 is an observational study that tracks outcomes without assigning an intervention. Its 4,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Comparing Manual and AI Patient Screening in Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which RECTIFIER - a generative artificial intelligence screening tool is the first listed.
NCT06588452 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06588452 about?
NCT06588452 is a clinical study titled "Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models". A prospective randomized controlled trial comparing manual review and AI screening for patient eligibility determination and enrollments. A structured query will identify potentially eligible patients from the Mass General Brigham Electronic Data Warehouse (EDW), who will then be randomized into eit...
What is the current status of trial NCT06588452?
This trial is currently recruiting. The enrollment target is 4,500 participants. The study started on 2024-03-04. Estimated completion is 2024-09-13.
What conditions does trial NCT06588452 study?
This clinical trial studies the following conditions: Comparing Manual and AI Patient Screening in Heart Failure.
What interventions are being tested in trial NCT06588452?
The interventions under investigation include: RECTIFIER - a generative artificial intelligence screening tool (OTHER), Manual clinical trial screening by study staff (OTHER).
Who is sponsoring clinical trial NCT06588452?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06588452 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
- NCT07165028 · 4,500 participants · Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- NCT07207564 · 4,500 participants
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
- NCT06252753 · 4,490 participants
Observational Study Protocol: LIVER-R
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI